Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 757 items.
The assay is out of specification in the affected lot(s).
RecallHealth product recall | 2022-05-13
COMIRNATY received a Notice of Compliance (NOC) under the Food and Drug Regulations on September 16, 2021, replacing the previous authorization under the Interim Order.
On March 15, 2022, COMIRNATY also received a NOC for an additional formulation…
AlertHealth professional risk communication | 2022-05-09
The complaint bottle contains Naphazolin HCl 0.013% and Glycern 0.26%.
RecallHealth product recall | 2022-05-09
Teva Canada Ltd. is recalling one lot each of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops because of a packaging error. Some bottles may contain ingredients that are not listed on the label and that may pose health…
AlertPublic advisory | 2022-05-07
Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid…
AlertPublic advisory | 2022-05-06
Presence of one (1) AA-FENO-SUPER 100 mg tablet in affected lot of AA-FENO-SUPER 160 mg.
RecallHealth product recall | 2022-05-05
The affected lot may contain Bio-Calcium D tablets.
RecallHealth product recall | 2022-05-02
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA).
RecallHealth product recall | 2022-04-28
Apotex Inc. is recalling certain lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a nitrosamine impurity (N-nitrosodimethylamine [NDMA]) above the acceptable level.
Apo-Acyclovir is a…
AlertPublic advisory | 2022-04-28
The affected lot is recalled due to a microbiological contamination.
RecallHealth product recall | 2022-04-27
Health Canada is warning consumers not to use unauthorized health products seized from three herbal medicine stores in Calgary, Alberta, because they are labelled to contain prescription drugs and may pose serious health risks. The products include skin…
AlertPublic advisory | 2022-04-22
The affected lots may contain an acetaldehyde concentration that is outside the acceptable limit.
RecallHealth product recall | 2022-04-21
UPDATE: April 21, 2022 – Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
Pfizer Canada ULC is recalling all lots of the prescription drug Accupril (quinapril hydrochloride) in 10 mg, 20 mg and 40 mg strengths due to the…
AlertPublic advisory | 2022-04-21
Presence of N-Nitroso-quinapril above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2022-04-20
Certain lots of hand sanitizers do not meet Health Canada requirements. Issues include:
containing (or possibly containing) ingredients that are not permitted by Health Canada;
containing undeclared impurities at elevated levels;
improper…
AlertPublic advisory | 2022-04-20